Flora Growth Corp.FLGCEarnings & Financial Report
Flora Growth Corp is a global cannabis and wellness enterprise cultivating, processing, and distributing premium cannabis and hemp-derived products including consumer goods, skincare lines, and therapeutic formulations. It operates mainly across Latin American, North American, and European markets, serving recreational and medicinal cannabis segments.
Revenue
$15.7M
Gross Profit
$3.2M
Operating Profit
$-3.5M
Net Profit
$-2.6M
Gross Margin
20.2%
Operating Margin
-22.6%
Net Margin
-16.8%
YoY Growth
-26.9%
EPS
$-0.21
Flora Growth Corp. Q4 FY2024 Financial Summary
Flora Growth Corp. reported revenue of $15.7M (down 26.9% YoY) for Q4 FY2024, with a net profit of $-2.6M (up 94.1% YoY) (-16.8% margin). Cost of goods sold was $12.5M, operating expenses totaled $6.7M.
Key Financial Metrics
| Total Revenue | $15.7M |
|---|---|
| Net Profit | $-2.6M |
| Gross Margin | 20.2% |
| Operating Margin | -22.6% |
| Report Period | Q4 FY2024 |
Flora Growth Corp. Annual Revenue by Year
Flora Growth Corp. annual revenue history includes year-by-year totals (for example, 2025 revenue was $28.7M).
| Year | Annual Revenue |
|---|---|
| 2025 | $28.7M |
| 2024 | $69.0M |
Flora Growth Corp. Quarterly Revenue & Net Profit History
Flora Growth Corp. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $-654.0K | +87.1% | $-109.9M | 16804.7% |
| Q1 FY2026 | $9.7M | -21.8% | $-6.7M | -68.3% |
| Q4 FY2025 | $14.8M | -5.7% | $-2.4M | -16.3% |
| Q3 FY2025 | $11.8M | -34.6% | $-758.0K | -6.4% |
| Q2 FY2025 | $-5.1M | -128.3% | $-6.1M | 120.5% |
| Q1 FY2025 | $7.2M | -58.2% | $-3.8M | -52.1% |
| Q4 FY2024 | $15.7M | -26.9% | $-2.6M | -16.8% |
| Q3 FY2024 | $18.0M | -6.7% | $-3.4M | -18.7% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0M | $15.7M | $7.2M | $-5.1M | $11.8M | $14.8M | $9.7M | $-654000 |
| YoY Growth | -6.7% | -26.9% | -58.2% | -128.3% | -34.6% | -5.7% | -21.8% | 87.1% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $24.3M | $30.1M | $29.3M | $26.2M | $22.4M | $22.7M | $74.0M | $130.2M |
| Liabilities | $21.1M | $21.8M | $24.1M | $21.7M | $17.6M | $18.6M | $9.1M | $59.7M |
| Equity | $3.1M | $7.3M | $4.3M | $4.5M | $4.8M | $4.0M | $64.9M | $70.6M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.3M | $-265000 | $-2.1M | $-1.3M | $-2.7M | $-2.9M | $100000 | $-3.2M |